Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 459.63% | 377.28% | 292.22% | 395.70% | -- |
| Total Depreciation and Amortization | -7.74% | 7.97% | 29.79% | 168.67% | -- |
| Total Amortization of Deferred Charges | 17.05% | 117.07% | -- | -- | -- |
| Total Other Non-Cash Items | 135.85% | 271.70% | 105.58% | 146.48% | -- |
| Change in Net Operating Assets | 34.63% | -65.44% | -- | -- | -- |
| Cash from Operations | 120.73% | 150.17% | 233.60% | 515.73% | -- |
| Capital Expenditure | -49.99% | -60.28% | -81.25% | -283.20% | -- |
| Sale of Property, Plant, and Equipment | 112.33% | 212.33% | -- | -- | -- |
| Cash Acquisitions | -- | 0.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -26.97% | -27.89% | -29.45% | -186.13% | -- |
| Cash from Investing | -31.55% | -33.90% | -37.87% | -201.89% | -- |
| Total Debt Issued | 76.09% | 176.09% | -- | -- | -- |
| Total Debt Repaid | -109.19% | -209.19% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -67.38% | -71.99% | -80.47% | -260.60% | -- |
| Other Financing Activities | -- | -72.75% | -72.75% | -72.75% | -- |
| Cash from Financing | -115.56% | -45.27% | 0.02% | 64.67% | -- |
| Foreign Exchange rate Adjustments | -550.50% | -109.86% | -57.92% | -65.83% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 327.71% | 259.16% | 205.63% | 127.31% | -- |